We’re Specialists in Surgical and Retinal Treatments for Connecticut, New York, and Beyond.

Current Clinical Studies

Diabetic Retinopathy

  • Protocol AC – Randomized Trial of Intravitreous Aflibercept vs. Intravitreous Bevacizumab + Deferred Aflibercept for Treatment of Central-Involved Diabetic Macular Edema
  • Protocol TX – A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
  • Protocol V – Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity
  • Protocol W – Intravenous Anti-VEGF Treatment for Prevention of Vision Threatening Diabetic Retinopathy in Eyes at High Risk
  • GEN-Genetics in Retinal Diseases Project


  • Adrenocorticotropic Hormone (ACTH) for the Treatment of Sarcoid Uveitis


Coming Soon…

Uveitis (March 2019)

  • A Phase 3, Multicenter, Sham-Controlled, Randomized, Double-Masked Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

Wet Age-Related Macular Degeneration (May 2019)

  • A Phase 2 Multicenter Dose-Ranging Study Evaluating the Safety and Efficacy of a Long-acting Intravitreal Sunitinib Malate Depot Formulation (GB-102) Compared to Intravitreal Aflibercept in Subjects with Neovascular (Wet) Age-related Macular Degeneration (PRELUDE Study)